MedPath

Evaluation of Safety and efficacy of hydrogen peroxide 35% topical solution, in Comparision to cryotherapy in on treatment of patients with senile lentigo referring to Shohada-e-Tajrish and Loghman-e-Hakim hospital in 1397-98.

Phase 3
Recruiting
Conditions
senile lentigo.
Registration Number
IRCT20190519043632N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
33
Inclusion Criteria

People with Fitzpatrick skin type 1-4
People without a history of drug allergy
Age over 16 years
No pregnancy or lactation
Failure to receive other treatments to eliminate lentigo in the last 6 weeks (such as cryotherapy or imiquimod ointment)
No Vitiligo

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effectiveness of the drug. Timepoint: One week, three weeks and three months. Method of measurement: Physical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath